| LORNA BOWES | PRIME PEOPLE
Sharon Brown, they were able to form the British Association of Cosmetic Nurses (BACN) with the blessing of the RCN. 'As a group we felt that the needs of
aesthetic nurses weren't being listened to,' she says. 'We felt that we needed a strong body that would be able to take forward the vast amount already achieved, like the RCN nurse competences that had been produced by the aesthetic nurse forum, and to provide a support network for aesthetic nurses in the UK.' The UK model is unique as most
aesthetic nurses throughout the world do not have the same treatment or prescribing rights, as the advanced nursing community in the UK.
Influencing policy The success of the BACN ® now with 650 members and rising ® has allowed them to contribute to and influence the UK Keogh report and the wider CEN throughout Europe. 'As far as the Keogh report is concerned,
when the BACN first discovered that there wasn't a nurse on the panel, they took immediate action, wrote to the DH, and put an in-depth document together detailing why nurses should be part of the panel, and why they should be able to do these treatments, whether they are prescription medicines or not,' Lorna explains. 'I'm a strong believer that you don't
have to be a nurse independent prescriber to work as a valid aesthetic nurse,' she continues. 'If you are working within your scope of practice as part of a team where there are prescribers ® whether that be a doctor, dentist or nurse ® within the team and working under their care, then you can provide an extremely high level of care. 'If you're going to work independently
then you absolutely have to be a nurse prescriber, because you need to be able to deal with the problems that aesthetic patients may come across and look after them holistically.'
Finding the niche Although Lorna was a founding member of the BACN, her professional career has meant that she hasn't always felt it ethical to sit on the board. Lorna's interest in dermatology was cemented during her nurse career at
Charing Cross Hospital in London, but she soon left the NHS to learn more about management and the pharmaceutical industry, during which time she applied for a role with the Collagen Corporation. She spent 2 years with this company training doctors, nurses and dentists to administer dermal fillers and offering business development support, after which she set up her own chain of clinics: the Bowes Clinics. 'We had clinics all over the UK and,
with a team of nurses, we delivered collagen injections and skin care, as well as hyaluronic acid fillers and botulinum toxin therapies when they appeared on the market.' Working to her
see a lot more technologies emerge within the next 5 years; particularly with regard to cosmetic dermatology with topical treatments, which can make a more fundamental change to the dermal components and structure.' (Such topical treatments may include
topical forms of botulinum toxin, for which Lorna says she has seen some good evidence in specific areas.) And one of the things hoped for, is a
I think that nurses are capable of learning
anatomy and physiology to a sufficiently high level to have cadaver training, ro understand where we're placing product, and to
original business plan she sold the successful business and went to work for Q-Med, taking part in their International Task Force and Group Expert Restylane. At that time, Q-Med and Italy were co-marketing the product with NeoStrata, which reinvigorated Lorna's interest in skin health as opposed to just needle technique Over the next few years working with
change to CE marking for dermal fillers, to resemble something more akin to the FDA approval process. 'CE marking is far
ensure that we are avoiding the critical areas .
too easy to achieve and while many consumers and patients don't understand the meanings of the various marks, neither do many practitioners, so
understanding the safety of the injectable products we select from those available to us is paramount to building a respected practice,' she says. 'It would be brilliant to have dermal
Q-Med, and then as head of Aesthetic Dermatology at Wigmore Medical, Lorna got to know many skincare ranges as well as having the opportunity to work with the full range of toxins and fillers. Her love of training like-minded aesthetic professionals and her passion for skincare (the NeoStrata brand in particular) ultimately led her to set up Aesthetic Source alongside her training and clinical practice.
Future development Despite such a successful and varied career, Lorna doesn't plan to rest on her laurels just yet, and has many thoughts on what the future may hold for the aesthetic and anti-ageing industry. 'I think that there will be more people
undergoing procedures, but also a greater move towards skin health alongside injectables and surgery,' she predicts. 'I think there will be a faster growth in the cosmeceutical sector, and that we'll
prime-journal.com | January/February 2013
fillers moved up into the prescription-only category, but I also think that skincare ingredients need to be looked at more closely, creating a formal cosmeceutical category.' However, perhaps what Lorna hopes
for most in the aesthetic industry, is that nurses continue to receive the support and recognition they deserve, continuing carrying out the treatments they are qualified to do: 'When you look at what nurses are
doing in the community and NHS, the procedures performed and the treatments UK nurses are now qualified to administer, the decisions they're able to take are so advanced compared with nursing 30 years ago. Aesthetic nursing can both learn from and positively influence the enhanced role of the UK nurse, as well as the wider aesthetic field '
❚
71
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92